Rituximab in refractory cutaneous polyarteritis.
Shanmuganandan
S
Krishnan
D S
DS
Bhakuni
S
S
Kartik
D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010488:Polyarteritis Nodosa / Q000188:drug therapy*; D000069283:Rituximab; D012871:Skin Diseases / Q000188:drug therapy*; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab